FORMULATION, OPTIMIZATION AND EVALUATION OF TERBUTALINE SULPHATE SOLID DISPERSED TABLETS FOR ENHANCED SOLUBILITY

AbstractTerbutaline Sulphate is a bronchodilator for which improvement in dissolution may be useful when rapid drug release is desired. Solid dispersion is a formulation approach that uses hydrophilic carriers to improve drug wettability and dissolution behaviour. The study aimed to formulate, optimize and evaluate Terbutaline Sulphate solid dispersions and tablets using polyvinylpyrrolidone K-30 (PVP K-30) and polyethylene glycol 6000 (PEG 6000) as hydrophilic carriers. Solid dispersions were prepared by the solvent evaporation method. The quantities of PVP K-30 and PEG 6000 were investigated using a 3² full factorial design. The prepared systems were characterized by FTIR, differential scanning calorimetry (DSC) and X-ray diffraction (XRD). Solid dispersions were compressed into tablets and evaluated for pre-compression and post-compression properties, drug content, in-vitro dissolution and short-term stability. The presentation reports drug content values of 95–99% across the solid dispersion batches. At 60 min, drug release from the batches ranged from 85.28% to 89.50%. The optimized tablet formulation (S1) showed 99.56 ± 0.62% drug content, hardness of 4.70 ± 0.12 kg/cm² and friability of 0.34 ± 0.03%. At 60 min, drug release was 95.63% in pH 1.2 medium and 96.28% in pH 6.8 medium. After 30 days at 25 ± 2°C/60 ± 5% RH, the reported physical and assay parameters showed no change, while disintegration time changed from 7.00 ± 0.41 to 7.60 ± 0.41 min. The findings indicate that preparation of Terbutaline Sulphate solid dispersions using hydrophilic carriers can improve in-vitro dissolution compared with the pure-drug tablet. The formulation and optimization results require confirmation against the original laboratory records because some formulation labels and optimization details in the presentation are inconsistent.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24361272
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

FORMULATION, OPTIMIZATION AND EVALUATION OF TERBUTALINE SULPHATE SOLID DISPERSED TABLETS FOR ENHANCED SOLUBILITY

Mahesh Mudigoudr, Neha Shivathaya, Megha Mudda, Prasanna Kabate et al.
Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

FORMULATION, OPTIMIZATION AND EVALUATION OF TERBUTALINE SULPHATE SOLID DISPERSED TABLETS FOR ENHANCED SOLUBILITY

Mahesh Mudigoudr, Neha Shivathaya, Megha Mudda, Prasanna Kabate, Ankita Thaikar
article en

Abstract

AbstractTerbutaline Sulphate is a bronchodilator for which improvement in dissolution may be useful when rapid drug release is desired. Solid dispersion is a formulation approach that uses hydrophilic carriers to improve drug wettability and dissolution behaviour. The study aimed to formulate, optimize and evaluate Terbutaline Sulphate solid dispersions and tablets using polyvinylpyrrolidone K-30 (PVP K-30) and polyethylene glycol 6000 (PEG 6000) as hydrophilic carriers. Solid dispersions were prepared by the solvent evaporation method. The quantities of PVP K-30 and PEG 6000 were investigated using a 3² full factorial design. The prepared systems were characterized by FTIR, differential scanning calorimetry (DSC) and X-ray diffraction (XRD). Solid dispersions were compressed into tablets and evaluated for pre-compression and post-compression properties, drug content, in-vitro dissolution and short-term stability. The presentation reports drug content values of 95–99% across the solid dispersion batches. At 60 min, drug release from the batches ranged from 85.28% to 89.50%. The optimized tablet formulation (S1) showed 99.56 ± 0.62% drug content, hardness of 4.70 ± 0.12 kg/cm² and friability of 0.34 ± 0.03%. At 60 min, drug release was 95.63% in pH 1.2 medium and 96.28% in pH 6.8 medium. After 30 days at 25 ± 2°C/60 ± 5% RH, the reported physical and assay parameters showed no change, while disintegration time changed from 7.00 ± 0.41 to 7.60 ± 0.41 min. The findings indicate that preparation of Terbutaline Sulphate solid dispersions using hydrophilic carriers can improve in-vitro dissolution compared with the pure-drug tablet. The formulation and optimization results require confirmation against the original laboratory records because some formulation labels and optimization details in the presentation are inconsistent.

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon